Landmark COVID-19 vaccine trial in sub-Saharan Africa is the first to study the efficacy of mRNA COVID-19 vaccines in people living with HIV

A highly anticipated clinical trial in eight sub-Saharan countries is the first to specifically evaluate the efficacy of a COVID-19 vaccine in people living with HIV, including those with poorly controlled infections. It also is the first study to...